Page 1527 - Small Animal Internal Medicine, 6th Edition
P. 1527

CHAPTER 96   Polysystemic Viral Diseases   1499


              manifesting in the central nervous system.  J Feline Med Surg.   Rottier PJ, et al. Acquisition of macrophage tropism during the
              2017;19:576.                                        pathogenesis of feline infectious peritonitis is determined
  VetBooks.ir  and reverse transcriptase-polymerase chain reaction of blood   Simons FA, et al. A mRNA PCR for the diagnosis of feline infec-
                                                                  by mutations in the feline coronavirus spike protein.  J Virol.
            Gunn-Moore DA, et al. Detection of feline coronaviruses by culture
                                                                  2005;79:14122.
              samples from healthy cats and cats with clinical feline infectious
              peritonitis. Vet Microbiol. 1998;62:193.            tious peritonitis. J Virol Methods. 2005;124:111.
            Harvey CJ, et al. An uncommon intestinal manifestation of feline   Stranieri A, et al. Comparison of the performance of laboratory
              infectious peritonitis: 26 cases (1986-1993). J Am Vet Med Assoc.   tests in the diagnosis of feline infectious peritonitis. J Vet Diagn
              1996;209:1117.                                      Invest. 2018;30:459.
            Hartmann K, Ritz S. Treatment of cats with feline infectious peri-  Tanaka Y,  et al. Suppression of feline coronavirus  replication  in
              tonitis. Vet Immunol Immunopathol. 2008;123:172.    vitro by cyclosporin A. Vet Res. 2012;43:41.
            Hazuchova K, et al. Usefulness of acute phase proteins in differen-  Tasker S. Diagnosis of feline infectious peritonitis: update on evi-
              tiating between feline infectious peritonitis and other diseases in   dence supporting available tests. J Feline Med Surg. 2018;20:228.
              cats with body cavity effusions. J Feline Med Surg. 2017;19:809.  Tekes G, et al. Feline coronaviruses: pathogenesis of feline infec-
            Ishida T, et al. Use of recombinant feline interferon and glucocor-  tious peritonitis. Adv Virus Res. 2016;96:193.
              ticoid  in  the  treatment  of  feline  infectious  peritonitis.  J Feline   Timmann D, et al. Retrospective analysis of seizures associated
              Med Surg. 2004;6:107.                               with feline infectious peritonitis in cats. J Feline Med Surg. 2008;
            Kim Y, et al. Broad-spectrum inhibitors against 3C-like proteases of   10:9.
              feline coronaviruses and feline caliciviruses. J Virol. 2015;89:4942.  Worthing KA, et al. Risk factors for feline infectious peritonitis in
            Legendre AM, Bartges JW. Effect of polyprenyl immunostimulant   Australian cats. J Feline Med Surg. 2012;14:405.
              on the survival times of three cats with the dry form of feline   Ziółkowska  N,  et al.  Feline  Infectious  Peritonitis:  immunohisto-
              infectious peritonitis. J Feline Med Surg. 2009;11:624.  chemical features  of ocular inflammation and  the distribution
            Legendre AM, et al. Polyprenyl immunostimulant treatment of cats   of viral antigens in structures of the eye. Vet Pathol. 2017;54:933.
              with presumptive non-effusive feline infectious peritonitis in a
              field study. Front Vet Sci. 2017;4:7.              Feline Immunodeficiency Virus
            Lewis  CS,  et al.  Genotyping  coronaviruses  associated with  feline   Arai  M,  et al.  The  use  of  human  hematopoietic  growth  factors
              infectious peritonitis. J Gen Virol. 2015;96:1358.  (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected
            Lewis KM, O’Brien RT. Abdominal ultrasonographic findings asso-  cats. Vet Immunol Immunopathol. 2000;77:71.
              ciated with feline infectious peritonitis: a retrospective review of   Baxter KJ, et al. Renal disease in cats infected with feline immuno-
              16 cases. J Am Anim Hosp Assoc. 2010;46:152.        deficiency virus. J Vet Intern Med. 2012;26:238.
            Longstaff L, et al. Feline coronavirus quantitative reverse tran-  Bęczkowski PM, et al. Contrasting clinical outcomes in two cohorts
              scriptase polymerase chain reaction on effusion samples in cats   of cats naturally infected with feline immunodeficiency virus
              with and without feline infectious peritonitis. J Feline Med Surg.   (FIV). Vet Microbiol. 2015;176:50.
              2017;19:240.                                       Burling AN, et al. Seroprevalences of feline leukemia virus and
            McDonagh P, et al. In vitro inhibition of feline coronavirus rep-  feline immunodeficiency virus infection in cats in the United
              lication  by  small  interfering  RNAs.  Vet Microbiol.  2011;150:   States and Canada and risk factors for seropositivity. J Am Vet
              220.                                                Med Assoc. 2017;251:187.
            Pedersen NC. An update on feline infectious peritonitis: virology   Butera ST, et al. Survey of veterinary conference attendees for evi-
              and immunopathogenesis. Vet J. 2014a;201:123.       dence of zoonotic infection by feline retroviruses. J Am Vet Med
            Pedersen NC. An update on feline infectious peritonitis: diagnos-  Assoc. 2000;217:1475.
              tics and therapeutics. Vet J. 2014b;201:133.       Chhetri BK, et al. Comparison of the geographical distribution of
            Pedersen NC, et al. The influence of age and genetics on natural   feline immunodeficiency virus and feline leukemia virus infec-
              resistance to experimentally induced feline infectious peritonitis.   tions in the United States of America (2000-2011).  BMC Vet
              Vet Immunol Immunopathol. 2014c;162:33.             Res. 2013;9:2.
            Pedersen NC, et al. Efficacy of a 3C-like protease inhibitor in treat-  Crawford PC, et al. Accuracy of polymerase chain reaction assays
              ing various forms of acquired feline infectious peritonitis. J Feline   for diagnosis of feline immunodeficiency virus infection in cats.
              Med Surg. 2017;20:378.                              J Am Vet Med Assoc. 2005;226:1503.
            Pedersen NC, et al. Levels of feline infectious peritonitis virus in   de Mari K, et al. Therapeutic effects of recombinant feline interferon-
              blood, effusions, and various tissues and the role of lymphopenia   omega on feline leukemia virus (FeLV)-infected and FeLV/feline
              in disease outcome following experimental infection. Vet Micro-  immunodeficiency virus (FIV)-coinfected symptomatic cats.  J
              biol. 2015;175:157.                                 Vet Intern Med. 2004;18:477.
            Pesteanu-Somogyi LD, et al. Prevalence of feline infectious perito-  Dickerson F, et al. Antibodies to retroviruses in recent onset psy-
              nitis in specific cat breeds. J Feline Med Surg. 2006;8:1.  chosis and multi-episode schizophrenia.  Schizophr Res. 2012;
            Riemer F, et al. Clinical and laboratory features of cats with feline   138:198.
              infectious  peritonitis–a  retrospective  study of 231  confirmed   Doménech A, et al. Use of recombinant interferon omega in feline
              cases (2000-2010). J Feline Med Surg. 2016;18:348.  retrovirosis: from theory to practice.  Vet Immunol Immuno-
            Rissi DR. A retrospective study of the neuropathology and diagno-  pathol. 2011;143:301.
              sis of naturally occurring feline infectious peritonitis. J Vet Diagn   Hartmann AD, et al. Clinical efficacy of melittin in the treatment
              Invest. 2018;30:392.                                of cats infected with the feline immunodeficiency virus. Tierarztl
            Ritz S, et al. Effect of feline interferon-omega on the survival time   Prax Ausg K Kleintiere Heimtiere. 2016;44:417.
              and quality of life of cats with feline infectious peritonitis. J Vet   Hartmann AD, et al. Clinical efficacy of the acyclic nucleoside phos-
              Intern Med. 2007;21:1193.                           phonate  9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine
   1522   1523   1524   1525   1526   1527   1528   1529   1530   1531   1532